Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Characterization of a missense variant in COG5 in a Tunisian patient with COG5-CDG syndrome and insights into the effect of non-synonymous variants on COG5 protein

    The clinical diagnosis of patients with multisystem involvement including a pronounced neurologic damage is challenging. High-throughput sequencing methods remains crucial to provide an accurate diagnosis. In ...

    Boudour Khabou, Umar Bin Mohamad Sahari, Abir ben Issa in Journal of Human Genetics (2024)

  2. Article

    Open Access

    A comprehensive analysis of minimally differentially methylated regions common to pediatric and adult solid tumors

    Cancer is the second most common cause of death in children aged 1–14 years in the United States, with 11,000 new cases and 1200 deaths annually. Pediatric cancers typically have lower mutational burden compar...

    David N. Buckley, Ben Yi Tew, Chris Gooden, Bodour Salhia in npj Precision Oncology (2024)

  3. Article

    Open Access

    Genetic landscape of interval and screen detected breast cancer

    Interval breast cancers (IBCs) are cancers diagnosed between screening episodes. Understanding the biological differences between IBCs and screen-detected breast-cancers (SDBCs) has the potential to improve ma...

    Charlie Mills, Amit Sud, Andrew Everall, Daniel Chubb in npj Precision Oncology (2024)

  4. Article

    Open Access

    DNA and RNA base editors can correct the majority of pathogenic single nucleotide variants

    The majority of human genetic diseases are caused by single nucleotide variants (SNVs) in the genome sequence. Excitingly, new genomic techniques known as base editing have opened efficient pathways to correct...

    Ariel Dadush, Rona Merdler-Rabinowicz, David Gorelik, Ariel Feiglin in npj Genomic Medicine (2024)

  5. Article

    Open Access

    ALK fusions in the pan-cancer setting: another tumor-agnostic target?

    Anaplastic lymphoma kinase (ALK) alterations (activating mutations, amplifications, and fusions/rearrangements) occur in ~3.3% of cancers. ALK fusions/rearrangements are discerned in >50% of inflammatory myofibro...

    Aditya Shreenivas, Filip Janku, Mohamed A. Gouda, Hui-Zi Chen in npj Precision Oncology (2023)

  6. Article

    Open Access

    Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations

    Identifying patients that are likely to respond to cancer immunotherapy is an important, yet highly challenging clinical need. Using 3139 patients across 17 different cancer types, we comprehensively studied t...

    Tian-Gen Chang, Yingying Cao, Eldad D. Shulman, Uri Ben-David in npj Precision Oncology (2023)

  7. Article

    Open Access

    Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade

    Immune checkpoint blockade (ICB) has demonstrated efficacy in patients with melanoma, but many exhibit poor responses. Using single cell RNA sequencing of melanoma patient-derived circulating tumor cells (CTCs...

    Douglas B. Fox, Richard Y. Ebright, **n Hong, Hunter C. Russell in npj Precision Oncology (2023)

  8. No Access

    Article

    A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer

    RAS oncogenes are major drivers of diverse types of cancer. However, they are largely not druggable, and therefore targeting critical downstream pathways and dependencies is an attractive approach. We have iso...

    Wuling Liu, Babu Gajendran, Klarke M. Sample, Chunlin Wang in Cancer Gene Therapy (2022)

  9. Article

    Open Access

    Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis

    Despite limited efficacy of immunotherapy for advanced non-small-cell lung cancer (NSCLC) with driver mutations, whether neoadjuvant immunotherapy could be clinically valuable in those patients warrants furthe...

    Chao Zhang, Hua-Fei Chen, Shi Yan, Lin Wu, Li-Xu Yan in npj Precision Oncology (2022)

  10. Article

    Open Access

    Publisher Correction: DNA-based copy number analysis confirms genomic evolution of PDX models

    Anna C. H. Hoge, Michal Getz, Anat Zimmer, Minjeong Ko, Linoy Raz in npj Precision Oncology (2022)

  11. Article

    Open Access

    Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer

    Fragmentation patterns of plasma cell-free DNA (cfDNA) are known to reflect nucleosome positions of cell types contributing to cfDNA. Based on cfDNA fragmentation patterns, the deviation in nucleosome footprin...

    Adriaan Vanderstichele, Pieter Busschaert, Chiara Landolfo in npj Genomic Medicine (2022)

  12. Article

    Open Access

    DNA-based copy number analysis confirms genomic evolution of PDX models

    Genomic evolution of patient-derived xenografts (PDXs) may lead to their gradual divergence away of their tumors of origin. We previously reported the genomic evolution of the copy number (CN) landscapes of PD...

    Anna C. H. Hoge, Michal Getz, Anat Zimmer, Minjeong Ko, Linoy Raz in npj Precision Oncology (2022)

  13. No Access

    Chapter

    CRISPR-Cas-Based Gene Therapy to Target Viral Infections

    In recent years, there is an increasing demand for the development of new antiviral strategies due to the prevalence of viral infections such as those caused by the human immunodeficiency (HIV) or the hepatiti...

    Mouraya Hussein, Ben Berkhout, Elena Herrera-Carrillo in Biotechnologies for Gene Therapy (2022)

  14. Article

    Open Access

    Whole genome sequencing and in vitro splice assays reveal genetic causes for inherited retinal diseases

    Inherited retinal diseases (IRDs) are a major cause of visual impairment. These clinically heterogeneous disorders are caused by pathogenic variants in more than 270 genes. As 30–40% of cases remain geneticall...

    Zeinab Fadaie, Laura Whelan, Tamar Ben-Yosef, Adrian Dockery in npj Genomic Medicine (2021)

  15. Article

    Open Access

    Gene therapy for spinal muscular atrophy: the Qatari experience

    Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder characterized by hypotonia, progressive muscle weakness, and wasting. Onasemnogene abeparvovec (Zolgensma®) is a novel gene therapy m...

    Hossamaldein Gaber Ali, Khalid Ibrahim, Mahmoud Fawzi Elsaid in Gene Therapy (2021)

  16. Article

    Open Access

    Broadening INPP5E phenotypic spectrum: detection of rare variants in syndromic and non-syndromic IRD

    Pathogenic variants in INPP5E cause Joubert syndrome (JBTS), a ciliopathy with retinal involvement. However, despite sporadic cases in large cohort sequencing studies, a clear association with non-syndromic inher...

    Riccardo Sangermano, Iris Deitch, Virginie G. Peter, Rola Ba-Abbad in npj Genomic Medicine (2021)

  17. Article

    Open Access

    Multiomics characteristics of neurogenesis-related gene are dysregulated in tumor immune microenvironment

    The success of immunotherapy was overshadowed by its low response rate, and the hot or cold tumor microenvironment was reported to be responsible for it. However, due to the lack of an appropriate method, it i...

    Ben Wang, Hai Mou, Mengmeng Liu, Zhujie Ran, **n Li, Jie Li in npj Genomic Medicine (2021)

  18. No Access

    Article

    Adenovirus vector-mediated YKL-40 shRNA attenuates eosinophil airway inflammation in a murine asthmatic model

    Recent studies have revealed that YKL-40 is involved in the pathogenesis of asthma. However, its specific mechanism remains unclear. The present study aims to investigate the effect of adenovirus vector-mediat...

    Ling Wang, Aihua Bao, Ying Zheng, Aying Ma, Yi Wu, Huanxia Shang in Gene Therapy (2021)

  19. Chapter

    Correction to: Application of iPSC to Modelling of Respiratory Diseases

    Ben A. Calvert, Amy L. Ryan (Firth) in Cell Biology and Translational Medicine, Volume 7 (2020)

  20. Chapter

    Application of iPSC to Modelling of Respiratory Diseases

    Respiratory disease is one of the leading causes of morbidity and mortality world-wide with an increasing incidence as the aged population prevails. Many lung diseases are treated for symptomatic relief, with ...

    Ben A. Calvert, Amy L. Ryan (Firth) in Cell Biology and Translational Medicine, Volume 7 (2020)

previous disabled Page of 3